Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PROCEPT BioRobotics (PRCT) Invested Capital (2020 - 2025)

Historic Invested Capital for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $431.8 million.

  • PROCEPT BioRobotics' Invested Capital rose 4755.96% to $431.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $431.8 million, marking a year-over-year increase of 4755.96%. This contributed to the annual value of $453.7 million for FY2024, which is 3661.68% up from last year.
  • Per PROCEPT BioRobotics' latest filing, its Invested Capital stood at $431.8 million for Q3 2025, which was up 4755.96% from $437.3 million recorded in Q2 2025.
  • PROCEPT BioRobotics' 5-year Invested Capital high stood at $453.7 million for Q4 2024, and its period low was -$206.3 million during Q2 2021.
  • For the 5-year period, PROCEPT BioRobotics' Invested Capital averaged around $271.1 million, with its median value being $303.2 million (2024).
  • As far as peak fluctuations go, PROCEPT BioRobotics' Invested Capital surged by 33675.11% in 2021, and later plummeted by 2848.44% in 2023.
  • PROCEPT BioRobotics' Invested Capital (Quarter) stood at $317.1 million in 2021, then dropped by 21.7% to $248.3 million in 2022, then soared by 33.75% to $332.1 million in 2023, then skyrocketed by 36.62% to $453.7 million in 2024, then dropped by 4.82% to $431.8 million in 2025.
  • Its Invested Capital stands at $431.8 million for Q3 2025, versus $437.3 million for Q2 2025 and $440.7 million for Q1 2025.